COPD New Triple Therapy & Guideline Update
COPD affects approximately 3 million Canadians, including 1.5 million Canadians who say they currently suffer from this disease and another 1.5 million undiagnosed Canadians. This makes COPD Canada's fourth leading cause of death. Join presenter Dr. Mohit Bhutani for this presentation on current management strategies for COPD.
About The Presenter - Dr. Mohit Bhutani, MD, FRCPC, FCCP
Dr. Bhutani is a Professor of Medicine at the University of Alberta. His main clinical interests are in the fields of Asthma and COPD, and his work has led him to be involved in many local, provincial, and national initiatives in these areas of specialty. He is currently the clinical director of the Asthma and COPD clinics at the University of Alberta. Provincially, he is the Co-chair of the Alberta Health Services (AHS) COPD Connect Care Pathway development program. From 2014-2020 he was co-chair of the Airways Working Group of the AHS Respiratory Health Strategic Clinical Network.
Nationally, he is the past Co-chair of the Canadian Thoracic Society (CTS) COPD Clinical Assembly. He was elected to the CTS Executive in 2020 and currently serves as Treasurer for the CTS. He is the current Co-chair of the Royal College of Physicians and Surgeons Adult Respiratory Examination. He has a number of research interests in both COPD and Asthma and has received research funding from many public and private granting agencies including CIHR and Alberta Innovates.
This webinar is sponsored by AstraZeneca.